for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Serum Completes Enrolment for Phase 3 Trial of AstraZeneca Vaccine in India

Nov 12 (Reuters) -

* INDIA MEDICAL RESEARCH BODY, SERUM INSTITUTE COMPLETE ENROLMENT FOR PHASE 3 TRIAL OF OXFORD-ASTRAZENECA COVID-19 VACCINE - STATEMENT

* SERUM INSTITUTE HAS PRODUCED 40 MILLION DOSES OF ASTRAZENECA VACCINE UNDER AT-RISK MANUFACTURING LICENSE FROM INDIA REGULATOR - STATEMENT

* ASTRAZENECA VACCINE CURRENTLY ‘MOST ADVANCED’ VACCINE IN HUMAN TESTING IN INDIA - INDIA MEDICAL RESEARCH BODY Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up